A recent study analyzed the TP53 mutational spectra of 7,525 pan-cancer tissues and found TP53 mutations in 35% of all 30 tumor-type samples, of which the most mutated cohorts are more than 80% and the lowest percentage of TP53 mutation was less than 1% [9]. Here, TP53 is linked to neoplasm.